Some scholars have shown that the overexpression of FSCN1 protein was related to the clinical malignant phenotype of non-small-cell lung adenocarcinoma, and it was a negative regulator of miR-145-5p, which inhibited the biological behaviors such as proliferation, cell cycle arrest, and apoptosis of non-small-cell lung adenocarcinoma cells [48]. Here, FSCN1 is linked to non-small cell lung adenocarcinoma.